目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Drug Type
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Parent Market Analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Drug Type outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Small Molecule CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rise in drug development pipelines
3.2.1.2. Growing reliance on CDMOS for cost-effective and specialized manufacturing services.
3.2.1.3. Capacity expansions by CDMOS
3.2.1.4. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. Growing demand for biologics
3.2.2.2. Complexity and challenges in synthesis of certain small molecules, impacting manufacturing efficiency
3.3. Small Molecule CDMO Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Small Molecule CDMO Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Active Pharmaceutical Ingredients (API)
4.1.2. Finished Drug Products
4.2. Product Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Small Molecule CDMO Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Active Pharmaceutical Ingredients (APIs)
4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Finished Drug Products
4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Small Molecule CDMO Market: Drug Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Innovators
5.1.2. Generics
5.2. Drug Type Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Small Molecule CDMO Market by Drug Type Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Innovators
5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Generics
5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Small Molecule CDMO Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Oncology
6.1.2. Cardiovascular Disease
6.1.3. Central Nervous System (CNS) Conditions
6.1.4. Autoimmune/Inflammation
6.1.5. Others
6.2. Application Market Share, 2023 & 2030
6.3. Segment Dashboard
6.4. Global Small Molecule CDMO Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Oncology
6.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Cardiovascular Disease
6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Central Nervous System (CNS) Conditions
6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Autoimmune/Inflammation
6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Others
6.5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Small Molecule CDMO Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
7.5. Europe
7.5.1. UK
7.5.1.1. Key Country Dynamics
7.5.1.2. Competitive Scenario
7.5.1.3. Regulatory Framework
7.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
7.5.2. Germany
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
7.5.3. France
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
7.5.4. Italy
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
7.5.5. Spain
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
7.5.6. Denmark
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
7.5.7. Sweden
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
7.5.8. Norway
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key Country Dynamics
7.6.1.2. Competitive Scenario
7.6.1.3. Regulatory Framework
7.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
7.6.2. India
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
7.6.4. South Korea
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
7.6.6. Thailand
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key Country Dynamics
7.7.1.2. Competitive Scenario
7.7.1.3. Regulatory Framework
7.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
7.7.2. Mexico
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key Country Dynamics
7.8.1.2. Competitive Scenario
7.8.1.3. Regulatory Framework
7.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
7.8.2. Saudi Arabia
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
7.8.3. UAE
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
7.8.4. Kuwait
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.1.1. Innovators
8.1.2. Market Leaders
8.1.3. Emerging Players
8.1.4. Company Market Share Analysis, 2023
8.2. Company Profiles
8.2.1. Lonza
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Service benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Catalent, Inc
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Service benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Thermo Fisher Scientific Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Service benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Cambrex Corporation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Service benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Bellen Chemistry
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Service benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Siegfried Holding AG
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Service benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Recipharm AB
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Service benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Eurofins Scientific
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Service benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Aurigene Pharmaceutical Services Ltd.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Service benchmarking
8.2.9.4. Strategic initiatives
8.2.10. CordenPharma International
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Service benchmarking
8.2.10.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America Small Molecule CDMO market, by region, 2018 - 2030 (USD Million)
Table 3 North America Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 4 North America Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 5 North America Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 7 U.S. Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 8 U.S. Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 9 Canada Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 10 Canada Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 11 Canada Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 12 Europe Small Molecule CDMO market, by region, 2018 - 2030 (USD Million)
Table 13 Europe Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 14 Europe Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 15 Europe Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 16 Germany Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 17 Germany Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 18 Germany Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 19 UK Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 20 UK Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 21 UK Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 22 France Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 23 France Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 24 France Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 25 Italy Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 26 Italy Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 27 Italy Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 28 Spain Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 29 Spain Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 30 Spain Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 31 Denmark Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 32 Denmark Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 33 Denmark Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 34 Sweden Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 35 Sweden Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 36 Sweden Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 37 Norway Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 38 Norway Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 39 Norway Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Small Molecule CDMO market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 44 China Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 45 China Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 46 China Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 47 Japan Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 48 Japan Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 49 Japan Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 50 India Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 51 India Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 52 India Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 53 South Korea Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 54 South Korea Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 55 South Korea Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 56 Australia Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 57 Australia Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 58 Australia Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 59 Thailand Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 60 Thailand Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 61 Thailand Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 62 Latin America Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 63 Latin America Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 64 Latin America Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 65 Brazil Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 66 Brazil Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 67 Brazil Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 68 Mexico Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 69 Mexico Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 70 Mexico Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 71 Argentina Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 72 Argentina Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 73 Argentina Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 74 MEA Small Molecule CDMO market, by region, 2018 - 2030 (USD Million)
Table 75 MEA Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 76 MEA Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 77 MEA Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 78 South Africa Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 79 South Africa Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 80 South Africa Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 84 UAE Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 85 UAE Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 86 UAE Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)
Table 87 Kuwait Small Molecule CDMO market, by Product, 2018 - 2030 (USD Million)
Table 88 Kuwait Small Molecule CDMO market, by Drug Type, 2018 - 2030 (USD Million)
Table 89 Kuwait Small Molecule CDMO market, by application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 QFD modeling for market share assessment
Fig. 11 Market formulation & validation
Fig. 12 Small Molecule CDMO market: market outlook
Fig. 13 Small Molecule CDMO competitive insights
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Industry value chain analysis
Fig. 17 Small Molecule CDMO market driver impact
Fig. 18 Small Molecule CDMO market restraint impact
Fig. 19 Small Molecule CDMO market: Product movement analysis
Fig. 20 Small Molecule CDMO market: Product outlook and key takeaways
Fig. 21 Active Pharmaceutical Ingredients (API) market estimates and forecast, 2018 - 2030
Fig. 22 Finished Drug Products estimates and forecast, 2018 - 2030
Fig. 23 Small Molecule CDMO Market: Drug Type Movement Analysis
Fig. 24 Small Molecule CDMO market: Drug Type outlook and key takeaways
Fig. 25 Innovators market estimates and forecast, 2018 - 2030
Fig. 26 Generics market estimates and forecast, 2018 - 2030
Fig. 27 Small Molecule CDMO market: application movement analysis
Fig. 28 Small Molecule CDMO market: application outlook and key takeaways
Fig. 29 Oncology market estimates and forecast, 2018 - 2030
Fig. 30 Cardiovascular Disease market estimates and forecast, 2018 - 2030
Fig. 31 Central Nervous System (CNS) Conditions market estimates and forecast, 2018 - 2030
Fig. 32 Autoimmune/Inflammation market estimates and forecast, 2018 - 2030
Fig. 33 Other market estimates and forecast, 2018 - 2030
Fig. 34 Global Small Molecule CDMO market: Regional movement analysis
Fig. 35 Global Small Molecule CDMO market: Regional outlook and key takeaways
Fig. 36 North America
Fig. 37 North America market estimates and forecast, 2018 - 2030
Fig. 38 U.S.
Fig. 39 U.S. market estimates and forecast, 2018 - 2030
Fig. 40 Canada
Fig. 41 Canada market estimates and forecast, 2018 - 2030
Fig. 42 Europe
Fig. 43 Europe market estimates and forecast, 2018 - 2030
Fig. 44 UK
Fig. 45 UK market estimates and forecast, 2018 - 2030
Fig. 46 Germany
Fig. 47 Germany market estimates and forecast, 2018 - 2030
Fig. 48 France
Fig. 49 France market estimates and forecast, 2018 - 2030
Fig. 50 Italy
Fig. 51 Italy market estimates and forecast, 2018 - 2030
Fig. 52 Spain
Fig. 53 Spain market estimates and forecast, 2018 - 2030
Fig. 54 Denmark
Fig. 55 Denmark market estimates and forecast, 2018 - 2030
Fig. 56 Sweden
Fig. 57 Sweden market estimates and forecast, 2018 - 2030
Fig. 58 Norway
Fig. 59 Norway market estimates and forecast, 2018 - 2030
Fig. 60 Asia Pacific
Fig. 61 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 62 China
Fig. 63 China market estimates and forecast, 2018 - 2030
Fig. 64 Japan
Fig. 65 Japan market estimates and forecast, 2018 - 2030
Fig. 66 India
Fig. 67 India market estimates and forecast, 2018 - 2030
Fig. 68 Thailand
Fig. 69 Thailand market estimates and forecast, 2018 - 2030
Fig. 70 South Korea
Fig. 71 South Korea market estimates and forecast, 2018 - 2030
Fig. 72 Australia
Fig. 73 Australia market estimates and forecast, 2018 - 2030
Fig. 74 Latin America
Fig. 75 Latin America market estimates and forecast, 2018 - 2030
Fig. 76 Brazil
Fig. 77 Brazil market estimates and forecast, 2018 - 2030
Fig. 78 Mexico
Fig. 79 Mexico market estimates and forecast, 2018 - 2030
Fig. 80 Argentina
Fig. 81 Argentina market estimates and forecast, 2018 - 2030
Fig. 82 Middle East and Africa
Fig. 83 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 84 South Africa
Fig. 85 South Africa market estimates and forecast, 2018 - 2030
Fig. 86 Saudi Arabia
Fig. 87 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 88 UAE
Fig. 89 UAE market estimates and forecast, 2018 - 2030
Fig. 90 Kuwait
Fig. 91 Kuwait market estimates and forecast, 2018 - 2030
Fig. 92 Market share of key market players - Small Molecule CDMO market